* Human relevant biomarker approaches for diagnosis of Alzheimer's * Proprietary products for neurodegeneration * Lined-up with 3 companies * Aim: 10% of the global market by 2030 * Raised: 100 k€ (1st round) + 350 k€ (2nd round) * Remaining: 4,15 m€
|Investor Role||Monthly Involvement|
It’s easy to create a pitch using our online form. Your pitch can be in front of our 201,377 investors before you know it.
It’s free to join the world’s largest angel investment community. You’ll then have full access to this pitch (and all the others) and be able to connect with entrepreneurs.